JPH0315604B2 - - Google Patents
Info
- Publication number
- JPH0315604B2 JPH0315604B2 JP21081782A JP21081782A JPH0315604B2 JP H0315604 B2 JPH0315604 B2 JP H0315604B2 JP 21081782 A JP21081782 A JP 21081782A JP 21081782 A JP21081782 A JP 21081782A JP H0315604 B2 JPH0315604 B2 JP H0315604B2
- Authority
- JP
- Japan
- Prior art keywords
- chitin
- weight
- toothpaste
- chitosan
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920002101 Chitin Polymers 0.000 claims description 46
- 239000000203 mixture Substances 0.000 claims description 32
- 229920001661 Chitosan Polymers 0.000 claims description 19
- 239000000606 toothpaste Substances 0.000 description 19
- 229940034610 toothpaste Drugs 0.000 description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 210000000214 mouth Anatomy 0.000 description 13
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 206010006326 Breath odour Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 235000019645 odor Nutrition 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 208000002925 dental caries Diseases 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- 201000001245 periodontitis Diseases 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000001680 brushing effect Effects 0.000 description 6
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 5
- 229960000458 allantoin Drugs 0.000 description 5
- 230000006196 deacetylation Effects 0.000 description 5
- 238000003381 deacetylation reaction Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 208000032139 Halitosis Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229940112822 chewing gum Drugs 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 4
- 239000002324 mouth wash Substances 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000000551 dentifrice Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 3
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 241000238421 Arthropoda Species 0.000 description 2
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- -1 acyl taurate Chemical compound 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 229940011037 anethole Drugs 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000206609 Porphyra Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- SFHUSLFRIKHKPE-UHFFFAOYSA-L chloro-[(2,5-dioxoimidazolidin-4-yl)carbamoylamino]aluminum;hydrate Chemical compound O.NC(=O)NC1NC(=O)N([Al]Cl)C1=O SFHUSLFRIKHKPE-UHFFFAOYSA-L 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229940105631 nembutal Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940037201 oris Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Description
本発明はキチン及びキトサンの少なくとも1種
を配合した口腔組成物に関する。
練歯磨、潤製歯磨、粉歯磨、液状歯磨などの歯
磨類、洗口剤、口中清涼剤、さらにはチユーイン
ガムなどの口腔組成物に、モノフルオロリン酸ナ
トリウム、イプシロン−アミノカプロン酸、塩酸
クロルヘキシジンなどの薬効成分を配合してウ蝕
予防、歯槽膿漏予防、口臭予防を図ることは従来
から実行されている。しかし、口腔組成物はいず
れも使用後吐き出されてしまうのが通例であり、
歯磨類にあつては使用後水で濯ぐのが慣例である
ので、薬効成分に所期の効果を期待するために
は、その配合量をかなり増加しなければならない
不利があつた。
ところで、節足動物の甲殻や軟体動物の骨に存
在し、カビの菌糸や胞子にも存在するキチンと、
その脱アセチル化物であるキトサンは、セルロー
スに類似した化学構造を有しているにも拘らず、
化学薬品に対する抵抗性はセルロースより遥かに
大きく、また分子内にアセトアミド基とアミノ基
を有しているため、多くの興味ある特性を備えて
いる。しかし、キチンやキトサン(以下、この両
者を総称してキチン等とも言う)は、セルロース
やその他の多糖類に比較してその利用度が極端に
低いのが実情である。
本発明者らはキチン等の有効利用を図るべく研
究を重ねた結果、キチン等は口腔組成物に従来配
合されていた薬効成分に優るとも劣らない薬効を
奏し、従つてこれを口腔組成物に配合すれば、ウ
蝕予防、歯槽膿漏予防及び口臭予防に有効な口腔
組成物が得られることを見い出した。
而して本発明に係る口腔組成物は、キチンとそ
の脱アセチル化物であるキトサンの少なくとも1
種を含有するものであり、従つて当然のことなが
ら、本発明の口腔組成物はキチンとキトサンの混
合物を含有することもある。
既述した通り、キチンは節足動物、軟体動物の
有機骨格物質として天然に存在し、植物ではカビ
の菌糸や胞子に存在するので、これらを原料とし
て公知の手段により取得することができる。例え
ばカニ、エビ、オキアミなどの甲殻を原料とする
場合には、甲殻を粉砕後塩酸で処理して炭酸カル
シウムを除き、さらにカ性ソーダで処理して蛋白
質その他の夾雑物を除いてから、水洗、乾燥する
ことにより、白色無定形の粉末状キチンを得るこ
とができる。またキトサンはアルカリ処理でキチ
ンを脱アセチル化することにより、白色無定形粉
末として得ることができる。しかし、本発明で使
用されるキチンの原料は上記の如き甲殻に限られ
ることはなく、各種のキチン源から任意の方法で
取得されるキチンやキトサンがいずれも使用可能
であつて、本発明では分子量の制約もない。また
本発明のキチン等には市販品も使用可能であつ
て、そうした市販品の一例としては、南陽化成株
式会社製の「REGITEX」(商品名)を挙げるこ
とができる。
尚、念のため付言すれば、キチンとキトサンと
の区分指標は学会でも確立されていないので、本
発明では脱アセチル化度が60%以上のものをキト
サン、それ以下のものをキチンと定義した。
本発明の口腔組成物では、キチン等による効果
を口腔組成物に発現させるうえで、その配合量は
少なくとも0.01重量%であることが必要である
が、許容配合量は個々の口腔組成物の種類によつ
て相違する。ちなみに、練歯磨にあつては0.01〜
70重量%、好ましくは0.05〜50重量%の配合量が
適当であつて、70重量%を越えた場合は押出し時
の成形性、保形性が損われる虞れがある。潤製歯
磨での配合量は0.01〜80重量%、好ましくは0.05
〜75重量%が適しており、80重量%を越えると潤
製歯磨状を保持できない。粉歯磨に於ける配合量
は0.01〜97重量%、好ましくは0.05〜95重量%が
適当であつて、97重量%を越えると、歯磨剤に必
要な発泡剤、甘味剤、香料などを配合する余地が
なくなるので望ましくない。また固型の口中清涼
剤ではキチン等の配合量を0.01〜70重量%、好ま
しくは0.05〜60重量%とするのが適当であり、70
重量%を越えた場合には、アラビアゴム液などに
よる粒状化が困難になる。液状歯磨、液状口中清
涼剤、洗口剤などの液状口腔組成物にあつては、
キチン等の配合量を0.01〜20重量%、好ましくは
0.05〜20重量%とするのが適当である。20重量%
を越える量ではたとえキチン等に可溶化処理が施
されていても、全量を液状組成物に溶かすことが
できず、また粘度も増大して実用的な液状口腔組
成物を得ることができない。チユーインガムにキ
チン等を配合する場合は、0.01〜60重量%、好ま
しくは0.05〜50重量%が適当である。60重量%を
越えるキチン等の配合は、ガムとして保形性を劣
化させ、食感を悪化させる。
本発明の口腔組成物に於て、キチン等以外の組
成物成分としては従来の口腔組成物に使用されて
いた成分がいずれも使用可能であつて、キチン等
の配合によつて他の成分の使用が制約されること
がない。例えば、歯磨類にあつては、グリセリ
ン、ソルビツト、プロピレングリコールなどの粘
稠剤、第二リン酸カルシウム、ピロリン酸カルシ
ウム、炭酸カルシウム、水酸化アルミニウム、水
性シリカ、火性シリカ、硫酸カルシウム、リン酸
マグネシウム、亜硫酸カルシウム、ゼオライト、
不溶性メタリン酸ナトリウムなどの研磨剤、カル
ボキシメチルセルロール、カラゲナンなどの粘結
剤、ラウリル硫酸ナトリウム、α−オレフインス
ルホン酸ナトリウム、ラウリン酸モノグリセライ
ドサルフエート、アシルタウレート、ラウリン酸
モノグリセライドスルホネート、ラウリルザルコ
シネートなどのアニオン活性剤、シヨ糖エステ
ル、ステアリン酸モノグリセライド、ラウリルジ
エタノールアマイド、ポリオキシエチレンソルビ
タンモノラウレートなどのノニオン活性剤、両性
活性剤、メントール、アネトールなどの香料、甘
味料、塩酸クロルヘキシジン、グルコン酸クロル
ヘキシジン、イプシロン−アミノカプロン酸、ジ
ヒドロコレスタノール、トラネキサム酸、アラン
トイン、アラントインクロルヒドロキシアルミニ
ウム、モノフルオロリン酸ナトリウム、デキスト
ラナーゼ、ポリエチレングリコール、塩化ナトリ
ウムなどの薬効成分、防腐剤、水などが使用され
る。同様にして口中清涼剤、洗口剤、チユーイン
ガムなどでも、通常これらに使用されている各種
の成分がキチン等と共に使用可能である。但し、
キチン等はウ蝕予防、歯槽膿漏予防、口臭予防に
効果があるので、この効果を期待して従来の口腔
組成物に配合されていた薬効成分の一部又は全部
が、本発明ではキチン等で代替できることはもち
ろんである。
次に実施例によつてキチン等のウ蝕予防効果、
歯槽膿漏予防効果及び口臭予防効果を具体的に説
明する。
実験例 1
本例及び次の実験例2はキチン等のウ蝕予防効
果に関する実験例である。
南陽化成株式会社製のキトサンREGITEX−
NA−50(分子量47000、脱アセチル化度77%)と
同じくREGITEX−NA−500(分子量114000、脱
アセチル化度60%)をそれぞれ微粉砕し、それぞ
れの200メツシユ篩通過品を実験に供した。キト
サン60mgを精秤し、これに精製水を加えて20mlと
し、得られた試料の乳酸中和能を乳酸水溶液
(200ppm)と電気化学計器株式会社製卓上型PH計
COM−10で測定した。結果を添付図面に示す。
図面からREGITEX−NA−50と同じくNA−500
の乳酸中和能はそれぞれ300ppm/mg及び
12ppm/mgであることがわかる。
実験例 2
後記の実施例1に示す組成Aの練歯磨1gを歯
ブラシに押出し、ローリング刷掃法で3分間歯を
磨き、水で充分濯いだ後、電気化学計器株式会社
製卓上型PH計(ガラスフラツト電極CE301S−
OT)を用いて舌上のPHを測定した。コントロー
ルとしては組成Aの練歯磨に於けるキトサンを水
で置き換えたものを使用した。また被験者には舌
上PH値が近似した成人男子10名を選択した。各被
験者の歯磨前の舌上PH値を表1に示す。
歯磨きによつて舌上PH値は歯磨前より上昇し、
その後経時的に減少するが、〔歯磨後のPH値−歯
磨前のPH値〕の経時変化を表2に示す。
The present invention relates to an oral composition containing at least one of chitin and chitosan. Sodium monofluorophosphate, epsilon-aminocaproic acid, chlorhexidine hydrochloride, etc. are used in dentifrices such as toothpaste, moisturized toothpaste, powdered toothpaste, and liquid toothpaste, mouth rinses, mouth fresheners, and even oral compositions such as chewing gum. It has been conventionally practiced to prevent caries, alveolar pyorrhea, and bad breath by incorporating medicinal ingredients. However, all oral compositions are typically spit out after use;
Since it is customary for toothpastes to be rinsed with water after use, the disadvantage is that in order to expect the desired effect from the medicinal ingredients, the amount of the medicinal ingredients must be increased considerably. By the way, chitin exists in the shells of arthropods and bones of molluscs, and also exists in the mycelia and spores of molds.
Although its deacetylated product, chitosan, has a chemical structure similar to cellulose,
Its resistance to chemicals is much greater than that of cellulose, and because it has acetamido and amino groups in its molecule, it has many interesting properties. However, the reality is that chitin and chitosan (hereinafter both are collectively referred to as chitin) are extremely less utilized than cellulose and other polysaccharides. As a result of repeated research aimed at the effective use of chitin, etc., the present inventors found that chitin, etc. has a medicinal effect that is superior to, if not inferior to, medicinal ingredients that have been conventionally incorporated into oral compositions. It has been found that when combined, an oral composition that is effective in preventing dental caries, alveolar pyorrhea, and halitosis can be obtained. Therefore, the oral composition according to the present invention contains at least one of chitin and chitosan, which is a deacetylated product thereof.
It should be understood that the oral compositions of the present invention may also contain a mixture of chitin and chitosan. As mentioned above, chitin exists naturally as an organic skeletal substance in arthropods and molluscs, and in plants in fungal hyphae and spores, so it can be obtained by known means using these as raw materials. For example, when using the shells of crabs, shrimp, krill, etc. as raw materials, the shells are crushed, treated with hydrochloric acid to remove calcium carbonate, and then treated with caustic soda to remove proteins and other impurities, and then washed with water. By drying, white amorphous powdered chitin can be obtained. Chitosan can also be obtained as a white amorphous powder by deacetylating chitin with alkali treatment. However, the chitin raw material used in the present invention is not limited to the above-mentioned shells, and any chitin or chitosan obtained by any method from various chitin sources can be used. There are no restrictions on molecular weight. Commercial products can also be used as the chitin of the present invention, and an example of such a commercial product is "REGITEX" (trade name) manufactured by Nanyo Kasei Co., Ltd. As a reminder, the classification index between chitin and chitosan has not been established even in academic societies, so in the present invention, we defined chitosan as having a deacetylation degree of 60% or more, and chitin as less than that. . In the oral composition of the present invention, in order for the oral composition to exhibit the effect of chitin etc., the amount of chitin etc. needs to be at least 0.01% by weight, but the permissible amount depends on the type of individual oral composition. It varies depending on. By the way, for toothpaste, it is 0.01~
A suitable blending amount is 70% by weight, preferably 0.05 to 50% by weight; if it exceeds 70% by weight, moldability and shape retention during extrusion may be impaired. The amount added in Junsei toothpaste is 0.01 to 80% by weight, preferably 0.05
~75% by weight is suitable, and if it exceeds 80% by weight, it will not be possible to maintain the moist toothpaste-like appearance. The appropriate amount of toothpaste to be added is 0.01 to 97% by weight, preferably 0.05 to 95% by weight, and if it exceeds 97% by weight, foaming agents, sweeteners, fragrances, etc. necessary for dentifrice are added. This is not desirable as there will be no room left. In addition, in solid mouth fresheners, it is appropriate that the amount of chitin etc. is 0.01 to 70% by weight, preferably 0.05 to 60% by weight, and 70% by weight.
If it exceeds the weight percentage, it becomes difficult to form particles using gum arabic liquid or the like. For liquid oral compositions such as liquid toothpaste, liquid mouth fresheners, and mouthwashes,
The amount of chitin etc. is 0.01 to 20% by weight, preferably
A suitable content is 0.05 to 20% by weight. 20% by weight
If the amount exceeds this amount, even if chitin or the like is solubilized, the entire amount cannot be dissolved in the liquid composition, and the viscosity will also increase, making it impossible to obtain a practical liquid oral composition. When chitin or the like is added to chewing gum, the appropriate amount is 0.01 to 60% by weight, preferably 0.05 to 50% by weight. Addition of more than 60% by weight of chitin etc. deteriorates the shape retention of the gum and worsens the texture. In the oral composition of the present invention, any of the ingredients used in conventional oral compositions can be used as composition ingredients other than chitin. There are no restrictions on its use. For example, for toothpaste, thickening agents such as glycerin, sorbitol, propylene glycol, dicalcium phosphate, calcium pyrophosphate, calcium carbonate, aluminum hydroxide, aqueous silica, pyrophoric silica, calcium sulfate, magnesium phosphate, sulfite, etc. calcium, zeolite,
Abrasives such as insoluble sodium metaphosphate, binders such as carboxymethyl cellulose and carrageenan, sodium lauryl sulfate, sodium α-olefin sulfonate, lauric acid monoglyceride sulfate, acyl taurate, lauric acid monoglyceride sulfonate, lauryl sarcoside Anionic active agents such as sucrose esters, stearic acid monoglyceride, lauryl diethanolamide, polyoxyethylene sorbitan monolaurate, amphoteric active agents, flavoring agents such as menthol and anethole, sweeteners, chlorhexidine hydrochloride, glucone Medicinal ingredients such as chlorhexidine acid, epsilon-aminocaproic acid, dihydrocholestanol, tranexamic acid, allantoin, allantoin chlorhydroxyaluminum, sodium monofluorophosphate, dextranase, polyethylene glycol, and sodium chloride, preservatives, and water are used. Ru. Similarly, various ingredients normally used in mouth fresheners, mouth rinses, chewing gum, etc. can be used together with chitin and the like. however,
Chitin and the like are effective in preventing dental caries, alveolar pyorrhea, and halitosis. Therefore, some or all of the medicinal ingredients that have been incorporated into conventional oral compositions in anticipation of these effects have been replaced with chitin and the like in the present invention. Of course, it can be replaced with Next, examples show the caries preventive effect of chitin, etc.
The effect of preventing alveolar pyorrhea and the effect of preventing bad breath will be specifically explained. Experimental Example 1 This example and the following Experimental Example 2 are experimental examples regarding the caries preventive effect of chitin and the like. Chitosan REGITEX manufactured by Nanyo Kasei Co., Ltd.
NA-50 (molecular weight 47,000, degree of deacetylation 77%) and REGITEX-NA-500 (molecular weight 114,000, degree of deacetylation 60%) were each finely ground, and the products that passed through a 200-mesh sieve were used for experiments. . Accurately weigh 60 mg of chitosan, add purified water to make 20 ml, and measure the lactic acid neutralization ability of the obtained sample using a lactic acid aqueous solution (200 ppm) and a desktop PH meter manufactured by Denki Kagaku Keiki Co., Ltd.
Measured with COM-10. The results are shown in the attached drawings.
From the drawing, it is NA-500 like REGITEX-NA-50.
The lactic acid neutralization ability of is 300ppm/mg and
It can be seen that it is 12ppm/mg. Experimental Example 2 1 g of toothpaste having the composition A shown in Example 1 below was extruded onto a toothbrush, the teeth were brushed using a rolling brushing method for 3 minutes, and after rinsing thoroughly with water, a tabletop PH meter (manufactured by Denki Kagaku Keiki Co., Ltd.) was used. Glass flat electrode CE301S−
PH on the tongue was measured using OT). As a control, a toothpaste of composition A in which chitosan was replaced with water was used. In addition, 10 adult males with similar PH values on the tongue were selected as subjects. Table 1 shows the pH values on the tongue of each subject before brushing their teeth. By brushing your teeth, the PH value on your tongue increases compared to before brushing your teeth.
Thereafter, it decreases over time, but Table 2 shows the change over time in [PH value after tooth brushing - PH value before tooth brushing].
【表】【table】
【表】
周知の通り、ウ蝕は炭水化物の分解、発酵によ
つて生じた有機酸(主として乳酸)が歯のエナメ
ル質を侵蝕(脱灰)するために起るものと説明さ
れ、その脱灰は口腔内のPH値が5.4以下で起ると
報告されている。従つて口腔内のPH値をほゞ7も
しくはそれ以上に保持することで予防することが
できる。ちなみに、本発明者らが行なつた別の実
験によれば、口腔内に0.2ppm濃度の乳酸を僅か
1ml添加するだけで、口腔内のPH値は5.4以下に
低下する。しかるに、本発明で使用されるキチン
等は、実験例1から明らかな通り、乳酸に対して
適度な中和能を有しており、また実験例2から明
らかな通り、キチン等を配合した歯磨剤は、これ
を配合していないコントロール歯磨剤に比較し
て、口腔内を長時間高いPH値に保持する能力を備
えている。これらの実験事実はキチン等がウ蝕予
防に有効であることを示すものに外ならない。
念のため付言すれば、実験例2に於てキチン等
を配合した歯磨を使用すると、口腔内を長時間比
較的高PH値に保持できるのは、キチン等の口腔内
滞留性が高いことに由来するものであるが、これ
はポリカチオンであるキチン等が、アニオン性を
示す口腔粘膜と複数の作用点で電気的に結合して
いるためと考えられる。
実験例 3
本例はキチン等の歯槽膿漏予防効果に関する実
験例である。
6週令のSlc−Wisterラツト(雄)の背部皮膚
をネンブタール麻酔下で除毛し、アルコール消毒
後、正中線に沿つて皮下筋膜に達する長さ4cmの
線状裂傷をメスで作成した。次に創傷剖を1cm置
きにミツヘル針で縫合し、4日後にミツヘル針を
外した。薬物は1日2回宛連続7日間創傷部全体
に塗布した。
創傷作製後7日目にラツトをクロロホルムで殺
して創傷部組織を剥離し、創傷線に直交する幅1
cmの皮膚片をラツトから3個採取し、インストロ
ンの張力測定機にて創傷部皮膚片の縫合部を引き
離すのに要する張力を測定して、その平均値を創
傷治癒の指標とした。ラツトは1群6匹とし、薬
物のコントロールとして生理食塩水を用いた。
使用した薬物の内容及びその投薬法とラツト群
との関係を表3に、またラツト群と創傷治癒効果
(引張強度)との関係を表4に示す。尚、表4中
の比率はラツト群Aの引張強度を100とし、これ
に対する相対値で表わした。[Table] As is well known, caries is caused by organic acids (mainly lactic acid) produced by the decomposition and fermentation of carbohydrates that erode (demineralize) tooth enamel. It has been reported that this occurs when the oral pH value is below 5.4. Therefore, it can be prevented by maintaining the pH value in the oral cavity at around 7 or higher. Incidentally, according to another experiment conducted by the present inventors, adding just 1 ml of lactic acid at a concentration of 0.2 ppm into the oral cavity lowers the PH value in the oral cavity to 5.4 or less. However, as is clear from Experimental Example 1, the chitin used in the present invention has a moderate ability to neutralize lactic acid, and as is clear from Experimental Example 2, toothpaste containing chitin, etc. The agent has the ability to maintain a higher pH value in the oral cavity for a longer period of time than a control toothpaste that does not contain this agent. These experimental facts prove that chitin etc. are effective in preventing dental caries. Just to be sure, in Experimental Example 2, when using a toothpaste containing chitin, etc., the reason why the oral cavity was able to maintain a relatively high PH value for a long time was due to the high retention of chitin in the oral cavity. This is thought to be because polycations such as chitin are electrically bonded to the anionic oral mucosa at multiple points of action. Experimental Example 3 This example is an experimental example regarding the preventive effect of chitin on alveolar pyorrhea. The dorsal skin of 6-week-old male Slc-Wister rats was removed under Nembutal anesthesia, and after disinfection with alcohol, a linear laceration with a length of 4 cm reaching the subcutaneous fascia was made with a scalpel along the midline. Next, the wound was sutured at 1 cm intervals using a Mitsuhel needle, and the Mitsuhel needle was removed 4 days later. The drug was applied to the entire wound twice a day for 7 consecutive days. Seven days after wound creation, rats were killed with chloroform, the wound tissue was peeled off, and a width of 1 mm perpendicular to the wound line was removed.
Three cm-sized skin pieces were taken from the rat, and the tension required to separate the sutures of the wound skin pieces was measured using an Instron tension measuring machine, and the average value was taken as an index of wound healing. There were 6 rats in each group, and physiological saline was used as a drug control. Table 3 shows the relationship between the contents of the drugs used and their dosing methods and the rat groups, and Table 4 shows the relationship between the rat groups and the wound healing effect (tensile strength). Note that the ratios in Table 4 are expressed as relative values with respect to the tensile strength of rat group A as 100.
【表】【table】
【表】
歯槽膿漏の薬物療法に於ては細胞賦活性作用
(創傷治癒効果)のある薬物が有効であるとされ
ている。細胞賦活性作用を有する薬物としては、
アラントイン系ものものが著名であり、アラント
イン、アルミニウムクロロヒドロキシアラントイ
ネート、アルミニウムジヒドロアラントイネート
などが従来から多く使用されて来た。本発明で使
用されるキチン等は、表4に示す結果から明らか
な通り、創傷治癒効果の点でアルミニウムジヒド
ロキシアラントイネートを凌ぐ薬効を発揮し、従
つてキチン等は歯槽膿漏の予防に有効であること
が理解できる。さらに付け加えれば、アラントイ
ン系の薬物はアルカリ側で分解が促進されるた
め、例えば歯磨に配合する場合は使用可能な活性
剤などが制約されてしまう問題があるが、キチン
等は化学的に安定であるため、上記の如き制約を
受けることがない。
実験例 4
本例はキトサンの口臭予防効果に関する実験例
である。
Bioshell Inc(635 Water Ave.E.、Albany、
Oregon 97321)製のキトサンLotNo.2200(分子量
88000、脱アセチル化度77%)を微粉砕し、200メ
ツシユ篩通過品を実験に供した。キトサンの1%
懸濁水20gを50mlの広口試薬ビンに精秤し、これ
に1.5ppmのメチルメルカプタン水溶液を一定量
添加して密栓した後、5分間37℃の恒温槽内に放
置した。しかる後、試薬ビンを開栓し、ヘツドス
ペースの臭気を官能評価してキトサンのメチルメ
ルカプタン吸着能を測定した。官能評価の評点は
表5に示す通り、メチルメルカプタン濃度
0.015ppmの時の臭気を1点、同0.045ppmの時の
臭気を3点、同0.15ppmの時の臭気を5点とし、
それぞれの中間の臭気を2点及び4点とする5段
階法を採用した。表5には各評点と人の口臭との
関係も表示した。[Table] In the drug treatment of alveolar pyorrhea, drugs that have a cell activating effect (wound healing effect) are said to be effective. Drugs with cell activation effects include:
Allantoin-based compounds are well known, and allantoin, aluminum chlorohydroxyallantoinate, aluminum dihydroallantoinate, etc. have been widely used. As is clear from the results shown in Table 4, chitin, etc. used in the present invention exhibits medicinal efficacy superior to aluminum dihydroxyallantoinate in terms of wound healing effects, and therefore, chitin, etc. is effective in preventing alveolar pyorrhea. It can be understood that Furthermore, allantoin-based drugs are decomposed in alkaline environments, which limits the active agents that can be used when they are added to toothpaste, but chitin and other drugs are chemically stable. Therefore, the above restrictions are not imposed. Experimental Example 4 This example is an experimental example regarding the halitosis preventive effect of chitosan. Bioshell Inc. (635 Water Ave.E., Albany)
Chitosan Lot No. 2200 (molecular weight
88000, deacetylation degree 77%) was finely ground and the product that passed through a 200 mesh sieve was used for the experiment. 1% of chitosan
20 g of suspension water was accurately weighed into a 50 ml wide-mouth reagent bottle, a fixed amount of 1.5 ppm methyl mercaptan aqueous solution was added thereto, the bottle was tightly stoppered, and the bottle was left in a constant temperature bath at 37° C. for 5 minutes. Thereafter, the reagent bottle was opened, and the odor in the head space was sensory evaluated to measure the methyl mercaptan adsorption ability of chitosan. As shown in Table 5, the sensory evaluation scores are based on methyl mercaptan concentration.
The odor at 0.015ppm is given 1 point, the odor at 0.045ppm is given 3 points, and the odor at 0.15ppm is given 5 points.
A 5-step method was adopted in which each intermediate odor was scored as 2 and 4 points. Table 5 also shows the relationship between each rating and human halitosis.
【表】【table】
【表】
口臭の原因物質はその90%以上がメチルメルカ
プタンと硫化水素であるとされているが、表6か
ら明らかな通り、本発明で使用するキチン等はメ
チルメルカプタン濃度6ppmまでの臭気を完全に
吸着する。メチルメルカプタン臭に対する人間の
臭気閾値は0.001ppm以上であることを考慮する
と、キチンなどは口臭予防に極めて有効であるこ
とがわかる。
進んで本発明に係る口腔組成物の具体的な組成
を実施例で示す。実施例の組成はいずれも重量%
である。
実施例 1
本例では練歯磨の組成例を示す。[Table] More than 90% of the substances that cause bad breath are said to be methyl mercaptan and hydrogen sulfide, but as is clear from Table 6, the chitin used in the present invention completely eliminates odors with methyl mercaptan concentrations up to 6 ppm. adsorbs to. Considering that the human odor threshold for methyl mercaptan odor is 0.001 ppm or higher, it can be seen that chitin is extremely effective in preventing bad breath. Next, the specific composition of the oral composition according to the present invention will be shown in Examples. All compositions in Examples are weight%
It is. Example 1 This example shows an example of the composition of a toothpaste.
【表】 実施例 2 本例は潤製歯磨の組成例を示す。【table】 Example 2 This example shows an example of the composition of a dentifrice.
【表】 実施例 3 本例では粉歯磨の組成例を示す。【table】 Example 3 This example shows an example of the composition of toothpaste powder.
【表】
実施例 4
本例は液状歯磨の組成例を示す。
グリセリン 35%
ポリアクリル酸ソーダ 5
パラフインスルホネート 1.5
サツカリン 0.1
香 料 1
モノフルオリン酸ナトリウム 0.76
水溶性キチン※4 0.5
リン酸二カリウム 0.1
リン酸一ナトリウム 0.2
水 バランス
計 100%
※4 Sannan Tらの方法〔Markromol.、
Chem.、1761191(1975)参照〕に準拠して調
製した水溶性キチン(脱アセチン化度48%)
実施例 5
本例は洗口剤の組成例を示す。[Table] Example 4 This example shows a composition example of a liquid toothpaste. Glycerin 35% Sodium polyacrylate 5 Paraphinsulfonate 1.5 Satucalin 0.1 Fragrance 1 Sodium monofluorophosphate 0.76 Water-soluble chitin *4 0.5 Dipotassium phosphate 0.1 Monosodium phosphate 0.2 Water Balance meter 100% *4 Method of Sannan T et al. [Markromol .,
Chem., 176 1191 (1975)] Water-soluble chitin (degree of deacetylation: 48%) Example 5 This example shows an example of the composition of a mouthwash.
【表】 実施例 6 本例はチユーインガムの組成例を示す。【table】 Example 6 This example shows an example of the composition of chewing gum.
【表】【table】
【表】 実施例 7 本例は液状口中清涼剤の組成例を示す。【table】 Example 7 This example shows a composition example of a liquid mouth freshener.
【表】
実施例 8
本例は固型の口中清涼剤組成を示す。
ペパーミント油 1%
レモン油 0.2
オイゲノール 0.1
アネトール 0.2
カルボン 0.3
キチン※2 20
キトサン※1 25
甘草粉末 30
キシリツト 7
オリス根末 4
ケイヒ粉末 3
シヨウキヨウ粉末 2
チヨウジ粉末 1
アラビアゴム液 バランス
計 100
※1、※2…実施例1参照
本例に示す固型口中清涼剤は、固体原料を充分
に粉末化して混合し、これに液体原料を加えてよ
く練り合わせ、これを粒状化することによつて調
製した。[Table] Example 8 This example shows a solid mouth freshener composition. Peppermint oil 1% Lemon oil 0.2 Eugenol 0.1 Anethole 0.2 Carvone 0.3 Chitin *2 20 Chitosan *1 25 Licorice powder 30 Xyrite 7 Oris root powder 4 Cinnamon powder 3 Porphyra powder 2 Powder powder 1 Gum arabic liquid Balance meter 100 *1, *2 ...See Example 1 The solid mouth freshener shown in this example was prepared by sufficiently powdering and mixing solid raw materials, adding liquid raw materials thereto, kneading well, and granulating this.
添付図面はキトサンの乳酸中和能を測定した実
験結果を示すグラフである。
The attached drawing is a graph showing the experimental results of measuring the lactic acid neutralizing ability of chitosan.
Claims (1)
することを特徴とする口腔組成物。1. An oral composition characterized by containing at least one of chitin and chitosan.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21081782A JPS59101416A (en) | 1982-11-30 | 1982-11-30 | Oral cavity composition |
US06/555,111 US4512968A (en) | 1982-11-30 | 1983-11-23 | Oral compositions |
GB08331706A GB2132889B (en) | 1982-11-30 | 1983-11-28 | Oral compositions |
DE19833343200 DE3343200A1 (en) | 1982-11-30 | 1983-11-29 | ORAL PREPARATION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21081782A JPS59101416A (en) | 1982-11-30 | 1982-11-30 | Oral cavity composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59101416A JPS59101416A (en) | 1984-06-12 |
JPH0315604B2 true JPH0315604B2 (en) | 1991-03-01 |
Family
ID=16595610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21081782A Granted JPS59101416A (en) | 1982-11-30 | 1982-11-30 | Oral cavity composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59101416A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0772123B2 (en) * | 1984-12-25 | 1995-08-02 | ライオン株式会社 | Plaque formation inhibitor composition |
JPS61216648A (en) * | 1985-03-20 | 1986-09-26 | Lion Corp | Food and drink |
JPS62193638A (en) * | 1986-02-20 | 1987-08-25 | Kao Corp | Granular agent |
DE19911055A1 (en) * | 1999-03-12 | 2000-09-21 | Cognis Deutschland Gmbh | Use of surface-active mixtures |
JP4708815B2 (en) * | 2005-03-07 | 2011-06-22 | サンスター株式会社 | Remineralization promoting composition |
JP2016074723A (en) * | 2015-12-03 | 2016-05-12 | ガバ・インターナショナル・ホールディング・アクチェンゲゼルシャフト | Mouthrinse composition |
-
1982
- 1982-11-30 JP JP21081782A patent/JPS59101416A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS59101416A (en) | 1984-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4512968A (en) | Oral compositions | |
AU2006320846B2 (en) | Vehicles for oral care with Magnolia Bark Extract | |
KR101308920B1 (en) | Composition and method for reducing demineralization of teeth | |
DE69918806T2 (en) | CHLORINE-CONTAINING MOIST CARE COMPOSITIONS | |
JP5625647B2 (en) | Dentifrice composition | |
US5711938A (en) | Oral hygiene composition | |
JP4261744B2 (en) | Oral composition | |
US4853213A (en) | Use of periwinkle in oral hygiene | |
US20220219020A1 (en) | Oral care composition | |
JPH0315604B2 (en) | ||
CN108430922B (en) | Mucin-coated silica for bacterial aggregation | |
US8337819B2 (en) | Pharmaceutical composition for the oral hygiene, the treatment of the periodontal illnesses and the halitosis | |
JP2005187329A (en) | Composition for oral cavity | |
JP2016124855A (en) | Oral hydrogel composition | |
JPS59152312A (en) | Oral cavity composition | |
JP3793625B2 (en) | Powder dentifrice composition | |
AU2017208371B2 (en) | Oral care composition | |
JP2003212743A (en) | Composition for oral cavity for hyperesthesia | |
KR20010011879A (en) | Manufacturing process of charcal toothpaste. | |
AU2003281744B2 (en) | Oral and dental composition | |
BRPI1103081A2 (en) | ORAL CARE PRODUCT COMPOSITIONS FOR THE DISPOSAL AND PREVENTION OF HALITOSIS (HALITOSIS) WITH ANTIBAFO, ANTISPTIC AND TEETH WHITE EFFECT | |
CA3050693A1 (en) | Oral care composition and use and method for the prevention and control of plaque formation, bad breath, gingivitis, periodontal diseases and/or dental caries | |
DE102018006887A1 (en) | Oral and dental care preparations | |
JP2017007992A (en) | Composition for oral cavity and method for improving bactericidal activity thereof | |
JPS61129110A (en) | Dentifrice agent for oral cavity treatment |